Medtronic
MDT
1,381 hedge funds and large institutions have $88.7B invested in Medtronic in 2018 Q1 according to their latest regulatory filings, with 98 funds opening new positions, 592 increasing their positions, 498 reducing their positions, and 108 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 592 | Existing positions reduced: 498
0.21% less ownership
Funds ownership: 81.79% → 81.59% (-0.21%)
1% less capital invested
Capital invested by funds: $89.4B → $88.7B (-$701M)
9% less first-time investments, than exits
New positions opened: 98 | Existing positions closed: 108
2% less funds holding
Funds holding: 1,408 → 1,381 (-27)
7% less funds holding in top 10
Funds holding in top 10: 43 → 40 (-3)
10% less call options, than puts
Call options by funds: $434M | Put options by funds: $485M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$799M |
| 2 |
LP
Longview Partners
St Peter Port,
Guernsey
|
+$580M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$443M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$309M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$282M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$722M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$701M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$592M |
| 4 |
State Street
Boston,
Massachusetts
|
-$373M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$217M |
MDT Hedge Fund Activity: Q1 2018 in Review
1,381 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2018, worth a combined $88.7B — down 0.78% from $89.4B a quarter earlier.
Sellers outnumbered buyers: 108 funds closed out of MDT and 98 opened new positions — a net loss of 10 holders — while 498 trimmed existing stakes and 592 added.
The largest buyer was JP Morgan Chase, adding an estimated $799M. The largest seller was Fidelity Investments, cutting an estimated $722M.
- 1,381 institutional investors held Medtronic (MDT) as of Q1 2018, down from 1,408 in Q4 2017.
- Funds reported $88.7B of Medtronic stock for Q1 2018, down 0.78% quarter-over-quarter.
- 98 funds opened new Medtronic positions in Q1 2018 and 108 closed out, a net change of -10 holders.
- The largest Medtronic buyer in Q1 2018 was JP Morgan Chase, an estimated $799M added.
- The largest Medtronic seller in Q1 2018 was Fidelity Investments, an estimated $722M sold.
Based on aggregated 13F filings for Q1 2018.